COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 138 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,074,588 | +22.5% | 48,080 | +17.8% | 0.00% | 0.0% |
| Q2 2023 | $877,394 | -7.5% | 40,828 | +3.3% | 0.00% | 0.0% |
| Q1 2023 | $948,061 | +12.0% | 39,519 | +8.3% | 0.00% | 0.0% |
| Q4 2022 | $846,591 | +107.5% | 36,491 | +43.1% | 0.00% | – |
| Q3 2022 | $408,000 | -8.9% | 25,494 | +0.8% | 0.00% | – |
| Q2 2022 | $448,000 | -13.0% | 25,297 | +0.0% | 0.00% | – |
| Q1 2022 | $515,000 | +16.8% | 25,285 | +7.1% | 0.00% | – |
| Q4 2021 | $441,000 | +1.4% | 23,614 | +7.2% | 0.00% | – |
| Q3 2021 | $435,000 | -32.5% | 22,030 | -19.1% | 0.00% | – |
| Q2 2021 | $644,000 | +0.5% | 27,229 | +0.6% | 0.00% | – |
| Q1 2021 | $641,000 | -14.6% | 27,057 | -27.7% | 0.00% | – |
| Q4 2020 | $751,000 | +46.4% | 37,444 | +51.7% | 0.00% | – |
| Q3 2020 | $513,000 | +29.9% | 24,687 | +9.3% | 0.00% | – |
| Q2 2020 | $395,000 | -13.8% | 22,579 | -19.5% | 0.00% | – |
| Q1 2020 | $458,000 | -46.9% | 28,060 | -33.0% | 0.00% | -100.0% |
| Q4 2019 | $863,000 | +177.5% | 41,901 | +54.9% | 0.00% | – |
| Q3 2019 | $311,000 | -57.2% | 27,054 | -51.1% | 0.00% | -100.0% |
| Q2 2019 | $727,000 | +73.9% | 55,296 | +100.6% | 0.00% | – |
| Q1 2019 | $418,000 | -6.1% | 27,565 | +6.3% | 0.00% | – |
| Q4 2018 | $445,000 | +44.5% | 25,933 | +24.1% | 0.00% | – |
| Q3 2018 | $308,000 | -56.2% | 20,904 | -29.1% | 0.00% | -100.0% |
| Q2 2018 | $703,000 | -63.8% | 29,464 | -61.3% | 0.00% | -50.0% |
| Q1 2018 | $1,944,000 | +262.7% | 76,084 | +161.6% | 0.00% | – |
| Q4 2017 | $536,000 | +177.7% | 29,084 | +57.8% | 0.00% | – |
| Q3 2017 | $193,000 | +40.9% | 18,432 | +35.2% | 0.00% | – |
| Q1 2017 | $137,000 | -29.4% | 13,630 | +9.4% | 0.00% | – |
| Q4 2016 | $194,000 | -14.9% | 12,457 | +5.1% | 0.00% | – |
| Q3 2016 | $228,000 | -30.1% | 11,847 | -56.9% | 0.00% | – |
| Q2 2016 | $326,000 | – | 27,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |